Could Lung Transplant Offer New Hope for Some Patients…

Could Lung Transplant Offer New Hope for Some Patients With Advanced Lung Cancer? For decades, stage IV non-small cell lung cancer (NSCLC) has generally been considered a condition treated with systemic therapies such as chemotherapy, targeted therapy, immunotherapy, or palliative care, not organ transplantation. But a new study published in JAMA is challenging that long-held assumption. Researchers found that lung transplantation was associated with encouraging early survival in a carefully selected group of patients with advanced lung cancer whose disease remained confined to the lungs. While the findings are preliminary, they may open a new chapter in the treatment of a small subset of patients with advanced lung cancer. Stage IV NSCLC is typically considered incurable because the cancer has spread. However, a small number of patients develop lung-limited stage IV disease, where the cancer remains confined to both lungs without spreading to other organs. Many of these patients eventually develop severe respiratory failure despite receiving all available medical treatments. Historically, lung transplantation has not been offered because of concerns that cancer would rapidly recur after surgery. Researchers at a single transplant center followed 98 adults with medically refractory, lung-limited stage IV NSCLC. Among them: 17 patients underwent